Abstract
The failure of signal transduction in the JCaM1 cell line was associated with the presence of an abnormal lck mRNA deleted of the exon 7 encoding for an inactive p56lck kinase. Our study of the lck mRNA from various T cell lines and from peripheral blood lymphocytes of healthy donors has revealed the presence of both complete and exon 7-deleted lck transcripts. Thus the exon 7-deleted lck transcript initially described in the JCaM1 mutant cell line, arises from an alternative splicing event occurring in each cells expressing the lck gene. Genomic DNA sequencing of the lck exons 6 – 8 portion from both the mutant JCaM1 and its parental Jurkat cell lines revealed as the only difference, the presence of a A to G mutation within the 5′ splice site of intron 7 in the JCaM1 cell line DNA. To demonstrate the role of this point mutation in the lck pre-mRNA maturation, COS cells were transfected by lck minigenes from the Jurkat and JCaM1 cell lines. In COS cells transfected with minigene from the Jurkat cell line both lck transcripts (with and without exon 7) were observed whereas only the exon 7-spliced lck transcript was observed in COS cells transfected with minigene from the JCaM1 cell line. Thus the mutation is per se responsible for the deletion of exon 7 and the absence of complete lck mRNA in the JCaM1 cell line. Presence of a restriction site (HphI) in the 5′ splice site of lck intron 7 from Jurkat DNA allowed to confirm the presence of the mutation on both alleles in the JCaM1 cell line.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burge C and Karlin S. . 1997 J. Mol. Biol. 268: 78–94.
Cance WG, Craven RJ, Bergman M, Xu L, Alitalo K and Liu ET. . 1994 Cell Growth Differ. 5: 1347–1355.
Carrera AC, Alexandrov K and Roberts TM. . 1993 Proc. Natl. Acad. Sci. USA 90: 442–446.
Cooke MP and Perlmutter RM. . 1989 New Biol. 1: 66–74.
Cooper JA. . 1990 In Peptides and Protein Phosphorylation. Kemp, B.E (ed). CRC Press, BOCA Raton, FL, USA pp. 85–113.
Guthrie C and Patterson B. . 1988 Annu. Rev. Genet. 22: 387–419.
Hsi ED, Siegel JN, Minami Y, Luong ET, Klausner RD and Samelson LE. . 1989 J. Biol. Chem. 264: 10836–10842.
Isakov N, Wange RL, Burgess WH, Watts JD, Aebersold R and Samelson LE. . 1995 J. Exp. Med. 181: 375–380.
Jamison SF, Pasman Z, Wang J, Will C, Lührmann R, Manley JL and Garcia-Blanco MA. . 1995 Nucleic Acids Res. 23: 3260–3267.
Jucker M, Abts H, Eick D, Lenoir GM and Tesch H. . 1991 Leukemia 5: 528–530.
Krawczak M, Reiss J and Cooper DN. . 1992 Hum. Genet. 90: 41–45.
Levy JB and Brugge JS. . 1989 Mol. Cell. Biol. 9: 3332–3341.
Perlmuter RM, Marth JD, Lewis DB, Peet R, Ziegler SF and Wilson CB. . 1988 J. Cell. Biochem. 38: 117–126.
Pyper JM and Bolen JB. . 1990 Mol. Cell. Biol. 10: 2035–2040.
Rouer E, Van Huynh T, Lavareda de Souza S, Lang MC, Fischer S and Benarous R. . 1989 Gene 84: 105–113.
Rouer E and Benarous R. . 1992 Oncogene 7: 2535–2538.
Rouer E, Dreyfus F, Melle J, Ribrag V and Benarous R. . 1993 Leukemia 7: 246–250.
Rouer E, Dreyfus F, Melle J and Benarous R. . 1994 Cell Growth Diff. 5: 659–666.
Stanley E, Ralph S, McEwen S, Boulet I, Holtzan DA, Lock P and Dunn AR. . 1991 Mol. Cell. Biol. 11: 3399–3406.
Straus DB and Weiss A. . 1992 Cell 70: 585–593.
Sudol M, Greulich H, Newman L, Sarkar A, Sukegawa J and Tadashi Y. . 1993 Oncogene 8: 823–831.
Takadera T, Leung S, Gernone A, Koga Y, Takihara Y, Miyamoto NG and Mak TW. . 1989 Mol. Cell. Biol. 9: 2173–2180.
Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM and Littman DM. . 1990 Cell 60: 755–765.
Van Oers NS, Killeen N and Weiss A. . 1996 J. Exp. Med. 183: 1053–1062.
Veillette A, Foss FM, Sausville EA, Bolen JB and Rosen N. . 1987 Oncogene Res. 1: 357–374.
Veillette A, Bookman MA, Horak EM and Bolen JB. . 1998 Cell 55: 301–308.
Voronova AF, Buss JE, Patschinsky T, Hunter T and Sefton BM. . 1985 Mol. Cell. Biol. 4: 2705–2713.
Xu H and Littman DR. . 1993 Cell 74: 633–643.
Yamanashi Y, Miyasaka M, Takeuchi M, Illic D, Mizuguchi J and Yamamoto T. . 1991 Cell Regulation 2: 979–987.
Zahler AM, Lane WS, Stolk JA and Roth MB. . 1992 Genes Dev. 6: 837–847.
Acknowledgements
We are grateful to Dr F Dreyfus for providing RNA from PBL of healthy donor, Dr C Beldjord for helpful discussion and F Letourneur for sequencing. This work was supported by grants from ANRS and ARC.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rouer, E., Brule, F. & Benarous, R. A single base mutation in the 5′ splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line. Oncogene 18, 4262–4268 (1999). https://doi.org/10.1038/sj.onc.1202720
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202720
Keywords
This article is cited by
-
A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature
Journal of Clinical Immunology (2024)
-
A novel link between Lck, Bak expression and chemosensitivity
Oncogene (2006)
-
Quantification of random genomic mutations
Nature Methods (2005)